CommercialPrior AuthMedium impact
Pharmacy Medical Policy Updates
Blue Cross Blue Shield of Kansas·KS · Endocrinology, Nephrology, Neurology +3 more·Pharmacy
Effective date
Sep 1, 2022
We identified it
Jun 19, 2026
Summary
BCBSKS updated pharmacy medical policies for five medication categories (Soliris/Ultomiris, Fintepla, Tavneos, Kerendia, and GLP-1 Agonists) effective September 1, 2022. Providers should check specific prior authorization requirements for these medications on the BCBSKS website.
Action Required
Review updated pharmacy medical policies for Soliris/Ultomiris, Fintepla, Tavneos, Kerendia, and GLP-1 Agonists on the BCBSKS prior authorization page at https://www.bcbsks.com/providers/precertification-prior-authorization. Billing team should verify current prior authorization requirements for these medications and update internal protocols accordingly.